Sort
51,570 grants matching “autoimmune disease”
Autoimmune Mechanisms in the Progression of CVD in Type 1 Diabetes
$381,413Myra A Lipes · Joslin Diabetes Center · R01 · FY2007 · DK
Dual TCR Expression Effects on Alloreactivity and Transplantation
$381,409Gerald Patrick Morris · University Of California, San Diego · R01 · FY2023 · AI
Investigating the Repertoires and Functions of T Cells that Help Autoreactive B Cells in Lupus
$381,404Mark J Shlomchik · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI
TL1A Regulation of Group 3 Innate Lymphoid Cells in Colitis
$381,375Randy S Longman · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · DK
TL1A Regulation of Group 3 Innate Lymphoid Cells in Colitis
$381,375Randy S Longman · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · DK
Origin and Function of Inflammatory Dendritic Cells in Psoriasis.
$381,375Michelle A Lowes · Rockefeller University · R01 · FY2012 · AR
Functions of SWAP-70 in B Cell Activation
$381,375Mount Sinai School Of Medicine Of Nyu · R01 · FY2005 · AI
Origin and Function of Inflammatory Dendritic Cells in Psoriasis.
$381,375Michelle A Lowes · Rockefeller University · R01 · FY2011 · AR
TL1A Regulation of Group 3 Innate Lymphoid Cells in Colitis
$381,375Randy S Longman · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DK
TL1A Regulation of Group 3 Innate Lymphoid Cells in Colitis
$381,375Randy S Longman · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · DK
Functions of SWAP-70 in B Cell Activation
$381,375Mount Sinai School Of Medicine Of Nyu · R01 · FY2004 · AI
Functions of SWAP-70 in B Cell Activation
$381,375Mount Sinai School Of Medicine Of Nyu · R01 · FY2003 · AI
Role of Abl Kinases in immune cell signaling
$381,372Ann Marie Pendergast · Duke University · R01 · FY2011 · AI
Molecular mechanisms of histone signaling in a chromatin relevant context
$381,357Catherine Anne Musselman · University Of Colorado Denver · R35 · FY2021 · GM
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
$381,330Jeffrey C Rathmell · Vanderbilt University Medical Center · R01 · FY2021 · DK
Targeted nanoscale antigen arrays for treating autoimmune diseases
$381,304Cory Berkland · University Of Kansas Lawrence · R56 · FY2012 · AI
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
$381,300Jeffrey C Rathmell · Vanderbilt University Medical Center · R01 · FY2022 · DK
Role of regulatory CD4+CD25+ T cells in diabetes
$381,267Brigham And Women'S Hospital · U01 · FY2003 · DK
Intracavitary Hemostatic Agent for Non-compressible Hemorrhage
$381,263Maja Nowakowski · Biomedica Management Corporation · R44 · FY2010 · HL
Mechano-ID for tagging immune cells
$381,260Khalid S. Salaita · Emory University · R01 · FY2024 · AI
Antiphospholipids in periodontitis
$381,250Harvey Allen Schenkein · Virginia Commonwealth University · R01 · FY2018 · DE
Tregulatory cells in myocarditis
$381,250Sally A. Huber · University Of Vermont & St Agric College · R01 · FY2012 · HL
ALLOANTIBODIES TO MHC INDUCES AUTOIMMUNITY AND OBLITERATIVE AIRWAY DISEASE (OAD)
$381,250Thalachallour Mohanakumar · Washington University · R01 · FY2015 · HL
UNDERSTANDING AUTOREACTIVE T CELL PATHOGENICITY
$381,250Brian Todd Edelson · Washington University · R01 · FY2015 · AI
Self-Reactive T Cell Development in Type 1 Diabetes
$381,250Matthew Bettini · University Of Utah · R01 · FY2021 · DK